| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome Acute Respiratory Distress Syndrome Network New England Journal of Medicine 342 (18), 1301-1308, 2000 | 7757 | 2000 |
| 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference MM Levy, MP Fink, JC Marshall, E Abraham, D Angus, D Cook, J Cohen, ... Critical care medicine 31 (4), 1250-1256, 2003 | 5791 | 2003 |
| HMG-1 as a late mediator of endotoxin lethality in mice H Wang, O Bloom, M Zhang, JM Vishnubhakat, M Ombrellino, J Che, ... Science 285 (5425), 248-251, 1999 | 4638 | 1999 |
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein JS Park, D Svetkauskaite, Q He, JY Kim, D Strassheim, A Ishizaka, ... Journal of Biological Chemistry 279 (9), 7370-7377, 2004 | 1971 | 2004 |
| The CRIT Study: anemia and blood transfusion in the critically ill—current clinical practice in the United States HL Corwin, A Gettinger, RG Pearl, MP Fink, MM Levy, E Abraham, ... Critical care medicine 32 (1), 39-52, 2004 | 1709 | 2004 |
| Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein CJ Fisher Jr, JM Agosti, SM Opal, SF Lowry, RA Balk, JC Sadoff, ... New England Journal of Medicine 334 (26), 1697-1702, 1996 | 1570 | 1996 |
| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1342 | 1994 |
| Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial E Abraham, K Reinhart, S Opal, I Demeyer, C Doig, AL Rodriguez, ... Jama 290 (2), 238-247, 2003 | 1254 | 2003 |
| Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1223 | 1995 |
| High mobility group box 1 protein interacts with multiple Toll-like receptors JS Park, F Gamboni-Robertson, Q He, D Svetkauskaite, JY Kim, ... American Journal of Physiology-Cell Physiology 290 (3), C917-C924, 2006 | 1145 | 2006 |
| Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death E Abraham, PF Laterre, R Garg, H Levy, D Talwar, BL Trzaskoma, ... New England Journal of Medicine 353 (13), 1332-1341, 2005 | 1140 | 2005 |
| Neutrophils and acute lung injury E Abraham Critical care medicine 31 (4), S195-S199, 2003 | 1119 | 2003 |
| Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, doubleblind, placebo-controlled, multicenter trial SM Opal, CJ Fisher, JFA Dhainaut, JL Vincent, R Brase, SF Lowry, ... Critical care medicine 25 (7), 1115-1124, 1997 | 1078 | 1997 |
| miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis G Liu, A Friggeri, Y Yang, J Milosevic, Q Ding, VJ Thannickal, N Kaminski, ... Journal of Experimental Medicine 207 (8), 1589-1597, 2010 | 1053 | 2010 |
| Cutting edge: HMG-1 as a mediator of acute lung inflammation E Abraham, J Arcaroli, A Carmody, H Wang, KJ Tracey The Journal of Immunology 165 (6), 2950-2954, 2000 | 971 | 2000 |
| Difinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis American College of Chest Physicians, ... Crit Care Med 20, 864-874, 1992 | 935 | 1992 |
| Transfusion-related acute lung injury: definition and review P Toy, MA Popovsky, E Abraham, DR Ambruso, LG Holness, PM Kopko, ... Critical care medicine 33 (4), 721-726, 2005 | 902 | 2005 |
| Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock E Abraham, A Anzueto, G Gutierrez, S Tessler, G San Pedro, ... The Lancet 351 (9107), 929-933, 1998 | 875 | 1998 |
| Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit CR Parikh, E Abraham, M Ancukiewicz, CL Edelstein Journal of the American Society of Nephrology 16 (10), 3046-3052, 2005 | 779 | 2005 |
| Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB K Asehnoune, D Strassheim, S Mitra, JY Kim, E Abraham The Journal of Immunology 172 (4), 2522-2529, 2004 | 628 | 2004 |
